ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 570,21
-0,82%
Dow Jones
40 211,72
0,00%
DAX
18 483,64
-0,63%
Brent Oil
82,95
-1,65%
Bitcoin
63 774,87
-1,66%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Allos Therapeutics, Inc. (MM) (ALTH)

  7. Allos Therapeutics, Inc. (MM) (ALTH) Actualités

ALTH

Allos Therapeutics, Inc. (MM) (ALTH)

Allos Therapeutics, Inc. (MM)
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:ALTH
DateHeureSourceTitreSymboleSociété
06/02/201218h46ZacksALTH Seeks Review of Folotyn Verdict - Analyst BlogNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
31/01/201223h18Edgar (US Regulatory)Current report filing (8-K)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
30/01/201214h30Business WireAllos Therapeutics Requests Re-Examination of CHMP Opinion on FOLOTYN® in PTCL at the European Medicines AgencyNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
30/01/201214h00Business WireAllos Therapeutics Announces Interim Results from Phase 1 Combination Study of FOLOTYN® & Bexarotene Demonstrate Activity in...NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
23/01/201213h00ZacksEuropean Setback for Allos - Analyst BlogNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
20/01/201213h43Business WireAllos Therapeutics Receives Negative Opinion from the CHMP on FOLOTYNNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
12/01/201218h15ZacksAllos Therapeutics Cut to Neutral - Analyst BlogNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
11/01/201214h15ZacksAMAG Q4 Sales Set to Disappoint - Analyst BlogNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
10/01/201214h00Business WireAllos Therapeutics Reports 2011 Financial Highlights and Key Business PrioritiesNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
23/12/201123h00Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
21/12/201114h00Business WireAllos Therapeutics Invites Investors to Listen to Webcast of Presentation at J.P. Morgan Healthcare ConferenceNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
15/12/201122h35Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
15/12/201116h00ZacksAMAG's Feraheme Gets Canada Nod - Analyst BlogNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
25/11/201113h15ZacksAllos Continues to Outperform - Analyst BlogNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
18/11/201114h00ZacksAMAG Hires Financial Advisor - Analyst BlogNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
08/11/201114h30ZacksAllos Narrows Loss - Analyst BlogNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
08/11/201110h15ZacksLoss Shrinks at AMAG, CEO Departs - Analyst BlogNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
04/11/201110h05ZacksCompany News for November 4, 2011 - Corporate SummaryNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
03/11/201112h07Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
03/11/201112h00Business WireAllos Therapeutics Reports Third Quarter 2011 Financial ResultsNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
26/10/201116h53Edgar (US Regulatory)Amended Statement of Beneficial Ownership (SC 13D/A)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
25/10/201110h14ZacksZacks #1 Rank Additions for Tuesday - Tale of the TapeNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
24/10/201117h00ZacksAMAG/Allos Deal Called Off - Analyst BlogNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
21/10/201115h27Business WireAllos Therapeutics Announces Termination of Merger Agreement with AMAG PharmaceuticalsNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
14/10/201112h02Edgar (US Regulatory)Filing of certain prospectuses and communications in connection with business combination transactions (425)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
14/10/201101h41Business WireAllos Therapeutics Announces Settlement with Putative Class Action Plaintiffs Regarding Merger with AMAG PharmaceuticalsNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
13/10/201114h16MarketwiredStrong Pipelines From Allos Therapeutics and Dynavax Tech Poised to Pay OffNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
10/10/201114h00Business WireAllos Therapeutics Continues to Work Toward Completion of Merger with AMAG PharmaceuticalsNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
23/09/201121h25Business WireRobbins Geller Rudman & Dowd LLP Files Class Action Suit against Allos Therapeutics, Inc.NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
16/09/201122h13Edgar (US Regulatory)Amended Current report filing (8-K/A)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
 Showing the most relevant articles for your search:NASDAQ:ALTH

Dernières Valeurs Consultées

EU
BEL20
Bel 20
EU
GLE
Societe Generale
EU
ACA
Credit Agricole
EU
AF
Air FranceKLM
EU
PX4
SBF 120
EU
BNP
BNP Paribas
COIN
ETHUSD
Ethereum
NYSE
DIS
Walt Disney
EU
VK
Vallourec
NYSE
MRK
Merck
EU
ML
Michelin
EU
ORA
Orange
EU
CAP
Capgemini
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés